Sfoglia per Autore
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
2013 Leoni, V; Caccia, C
Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid
2013 Leoni, V; Caccia, C
Biomarker report from the phase II lamotrigine trial in secondary progressive MS – neurofilament as a surrogate of disease progression
2013 Gnanapavan, S; Grant, D; Morant, S; Furby, J; Hayton, T; Teunissen, C; Leoni, V; Marta, M; Brenner, R; Palace, J; Miller, D; Kapoor, R; Giovannoni, G
Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression
2013 Leoni, V; Long, J; Mills, J; Di Donato, S; Paulsen, J
Pitfalls in the detection of cholesterol in Huntington's disease models
2012 Marullo, M; Valenza, M; Leoni, V; Caccia, C; Scarlatti, C; De Mario, A; Zuccato, C; Di Donato, S; Carafoli, E; Cattaneo, E
Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms
2012 Besga, A; Cedazo-Minguez, A; Kåreholt, I; Solomon, A; Björkhem, I; Winblad, B; Leoni, V; Hooshmand, B; Spulber, G; Gonzalez-Pinto, A; Kivipelto, M; Wahlund, L
Inverse correlation between plasma oxysterol and LDL-cholesterol levels in hepatitis C virus-infected patients
2012 Arciello, M; Petta, S; Leoni, V; Iannucci, G; Labbadia, G; Cammà, C; Craxì, A; Balsano, C
Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations
2012 Leoni, V; Strittmatter, L; Zorzi, G; Zibordi, F; Dusi, S; Garavaglia, B; Venco, P; Caccia, C; Souza, A; Deik, A; Clish, C; Rimoldi, M; Ciusani, E; Bertini, E; Nardocci N, ; Mootha, V; Tiranti, V
Oxysterols as biomarkers in neurodegenerative diseases
2011 Leoni, V; Caccia, C
Whole body cholesterol metabolism is impaired in Huntington's disease
2011 Leoni, V; Mariotti, C; Nanetti, L; Salvatore, E; Squitieri, F; Bentivoglio, A; Bandettini Del Poggio, M; Piacentini, S; Monza, D; Valenza, M; Cattaneo, E; Di Donato, S
Metabolic Consequences Of Coenzyme A Deficiency In Patients With Pank2 Mutations
2011 Leoni, V; Caccia, C; Ciusani, E; Tiranti, V
Oxysterols and cholesterol metabolism in neurodegenerative disease. A metabolic approach
2011 Leoni, V; Caccia, C; Tiranti, V
Cholesterol metabolism in Huntington’s Disease
2011 Leoni, V; Caccia, C; Björkhem, I
Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease
2011 Mateos, L; Ismail, M; Gil-Bea, F; Leoni, V; Winblad, B; Björkhem, I; Cedazo-Mínguez, A
Relationship between cholesterol metabolism, ApoE and brain volumes in Alzheimer’s disease
2011 Leoni, V; Caccia, C
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 alpha Contributes to Dysmyelination in Experimental Models of Huntington's Disease
2011 Xiang, Z; Valenza, M; Cui, L; Leoni, V; Jeong, H; Brilli, E; Zhang, J; Peng, Q; Duan, W; Reeves, S; Cattaneo, E; Krainc, D
High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: Fact or fi ction?
2011 Björkhem, I; Lövgren-Sandblom, A; Piehl, F; Khademi, M; Pettersson, H; Leoni, V; Olsson, T; Diczfalusy, U
The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
2011 Leoni, V
Links between ApoE, brain cholesterol metabolism, tau and amyloid β-peptide in patients with cognitive impairment
2010 Leoni, V; Solomon, A; Kivipelto, M
Cerebral and extracerebral cholesterol biosynthesis is impaired in HD patients
2010 Leoni, V; Mariotti, C; Nanetti, L; Tomasello, C; Salvatore, E; Di Michele, G; Soletti, F; Bentivoglio, A; Bandettini del Poggio, M; Abbruzzese, G; Piacentini, S; Squitieri, F; Valenza, M; Cattaneo, E; Di Donato, S
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile